Orchid Pharma is down almost 4% at Rs.12.55. The stock’s 52-week high and low stands at Rs.39.70 and Rs.10.60.

The stock is down on account of its very poor performance for Q4FY18. The company posted a 20% (YoY) drop in revenue at Rs.144 crore. It hasn’t  posted a net profit in a long while – its net loss for Q4 widened to Rs.77 crore from Rs.65 crore.

The company’s operating profit was down 31% at Rs.13.5 crore and margins slipped from 10.8% to 9.4%.